A Case of X-Linked Hypophosphatemia: Exploring the Burden in a Single Family and the Significance of a Multidisciplinary Approach
Article Sidebar
Main Article Content
Abstract
A 46-year-old lady was diagnosed clinically with X-linked hypophosphatemia (XLH) with a rare pathogenic variant detected using exome sequencing. Phosphate-regulating endopeptidase homologous X linked (PHEX) is normally expressed in osteoblasts and osteocytes, and senses phosphate regulation. More than 1000 PHEX variants have been detected to date, which are caused by missense, nonsense, and frameshift mutations in addition to splice variants and copy number changes. The aberration in the PHEX gene leads to the upregulation of fibroblastic growth factor 23 (FGF23), which leads to defects in phosphate metabolism. This results in impaired bone growth and mineralization, short and disproportionate stature, leg bowing, musculoskeletal pain, spontaneous dental abscesses, rickets, and osteomalacia in XLH patients. The spectrum of manifestations differs between pediatric and adult patients. In our case study, two of the patient’s children started showing symptoms at a younger age, unlike their mother. Timely diagnosis and the start of treatment would help in their better management and improved quality of life.
Article Details
Copyright (c) 2023 Kaler AK, et al.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The Archives of Case Reports is committed in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. In order to use the Open Access paradigm to the maximum extent in true terms as free of charge online access along with usage right, we grant usage rights through the use of specific Creative Commons license.
License: Copyright © 2017 - 2025 | 
Open Access by Archives of Case Reports is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at Heighten Science Publications Inc.
With this license, the authors are allowed that after publishing with the journal, they can share their research by posting a free draft copy of their article to any repository or website.
Compliance 'CC BY' license helps in:
| Permission to read and download | ✓ |
| Permission to display in a repository | ✓ |
| Permission to translate | ✓ |
| Commercial uses of manuscript | ✓ |
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
Ichikawa S, Traxler EA, Estwick SA, Curry LR, Johnson ML, Sorenson AH. Mutational survey of the PHEX gene in patients with X-linked hypophosphatemic rickets. Bone. 2008; 43(4):663-6.
Ruppe MD. X-Linked Hypophosphatemia. In: Adam MP, Mirzaa GM, Pagon RA. editors. GeneReviews®. Seattle (WA): University of Washington, Seattle; 1993-2023. 2012. https://www.ncbi.nlm.nih.gov/books/NBK83985/
Sarafrazi S, Daugherty SC, Miller N, Boada P, Carpenter TO, Chunn L. Novel PHEX gene locus-specific database: Comprehensive characterization of vast number of variants associated with X-linked hypophosphatemia (XLH). Hum Mutat. 2022; 43(2):143-157.
Beck-Nielsen SS, Brixen K, Gram J, Brusgaard K. Mutational analysis of PHEX, FGF23, DMP1, SLC34A3 and CLCN5 in patients with hypophosphatemic rickets. J Hum Genet. 2012; 57(7):453-8.
Song HR, Park JW, Cho DY, Yang JH, Yoon HR, Jung SC. PHEX Gene Mutations and Genotype-Phenotype Analysis of Korean Patients with Hypophosphatemic Rickets. J Korean Med Sci. 2007;22(6):981-986.
Novel PHEX Variants and Splicing Mutations in Patients with X-Linked Hypophosphatemia. Research Square Xing X, Gao J, Ma H. 2021.
Padidela R, Nilsson O, Makitie O. The international X-linked hypophosphataemia (XLH) registry (NCT03193476): rationale for and description of an international, observational study. Orphanet J Rare Dis. 2020; 15:172.
Zhang C, Zhao Z, Sun Y. Clinical and genetic analysis in a large Chinese cohort of patients with X-linked hypophosphatemia. Bone. 2019; 121:212-220.
Popowska E, Pronicka E, Sułek A, Jurkiewicz D, Rowe P, Rowinska E. X-linked hypophosphatemia in Polish patients. 1. Mutations in the PHEX gene. J Appl Genet. 2000; 41(4):293-302.
Fahiminiya S, Almuriekhi M, Nawaz Z, Staffa A, Lepage P, Ali R. Whole exome sequencing unravels disease-causing genes in consanguineous families in Qatar. Clin Genet. 2014;86(2):134-41.
Cabrera BMJ, Chacha OPR, Reza-Albarrán AA, Chacha OAK, Acero MA, Serrano RA. X-linked hypophosphatemic rickets: Case report of late diagnosis and bone pain improvement with targeted treatment. Clin Case Rep. 2022;10(8): e6217.
Baroncelli GI, Mora S. X-Linked Hypophosphatemic Rickets: Multisystemic Disorder in Children Requiring Multidisciplinary Management. Front Endocrinol (Lausanne). 2021 Aug 6; 12:688309. doi: 10.3389/fendo.2021.688309. PMID: 34421819; PMCID: PMC8378329.
Haffner D, Emma F, Eastwood DM, Duplan MB, Bacchetta J, Schnabel D, Linglart A. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nature Reviews Nephrology. 2019; 15(7):435-455.
Lo SH, Lachmann R, Williams A, Piglowska N, Lloyd AJ. Exploring the burden of X-linked hypophosphatemia: A European multi-country qualitative study. Qual Life Res.2020;29(7):1883-1893.
Kanamalla K, Fuchs R, Herzog C, Steigbigel KD, Macica CM. An Evidence-based Physical Therapy Prescription for Adults with X-linked Hypophosphatemia. J Endocr Soc. 2022 Jun 18; 6(8): bvac094.